The purpose of this study was to evaluate factors influencing the use of propofol-based total intravenous anaesthesia (TIVA) since despite TIVA being a well-established technique, it is used far less frequently than volatile anaesthesia. Questions were formulated after reviewing the literature for perceived disadvantages of TIVA and meeting with a focus group consisting of both senior and junior anaesthestists from our department. Once the survey had been formulated, specialist anaesthetists from professional colleges and societies from several countries were invited to complete the survey on an electronic webbased platform to allow evaluation of the respondent's rating of the importance of a range of factors in their decision not to use TIVA for a particular case. Basic descriptive statistics were determined using SPSS statistical software, while graphical depictions of data were handled using R for statistical analysis. A total of 763 survey responses were included in the final analysis and stratified according to the frequency of TIVA use. Among the infrequent users, issues such as additional effort, institutional preference, lack of real-time monitoring of propofol concentration, risk of missing drug delivery failure and increased turnaround time were among the top reasons mentioned. Interestingly, these issues were considered far less important among the frequent users when not choosing TIVA. We concluded that frequent and infrequent users respond quite differently to similar technical TIVA-related factors. Non-technical factors may play an important role in the infrequent user's decision not to use TIVA for a particular case.
. As propofol concentration at loss of consciousness corresponds remarkably well with that at return of consciousness 4 , TIVA with TCI also allows excellent titration. In the last 20 years, open TCI systems in 'smart' pumps using generic propofol have improved safety and reduced drug costs 5 . Remifentanil is a fast-onset opioid with a consistently short contextsensitive half-life which makes it suitable for combination with propofol for the analgesic component of TIVA 2, 6 . While some of the advantages of TIVA are well known, such as its rapid and smooth recovery profile and reduction in postoperative nausea and vomiting [7] [8] [9] , others are being increasingly recognised such as lower emergence agitation in children and less pain after surgery 10 . Recent research even suggests that long-term survival after cancer surgery may be improved in patients anaesthetised with TIVA compared to volatile anaesthesia 11 . While the disadvantages associated with TIVA remain relatively unchanged, the conditions for using TIVA continue to improve, and advantages with its use continue to be uncovered. However, TIVA accounts for only a small percentage of general anaesthetics even in countries where it is well established 12 . Against this background and based on existing perceived disadvantages from the literature, we designed a survey to investigate this. Our aim was to investigate the relative importance different users place on each factor to see whether any patterns could be identified.
Materials and methods
A literature search was performed for publications that discuss the advantages and disadvantages of TIVA use. Search terms used were 'total intravenous anaesthesia', 'propofol anaesthesia', 'target controlled infusion', 'pros, cons, advantages, disadvantages' and a combination thereof. Based on the factors identified by the literature search, a preliminary questionnaire was developed. This pilot questionnaire was tested on a focus group of senior and junior anaesthetists from our department, a teaching hospital and 1,600 bed tertiary referral centre in Hong Kong. Questions were refined after feedback and finalised into the distributed survey (see appendix for full survey). Notably we phrased some of the questions in a negative sense to identify 'barriers' to using TIVA in both infrequent and frequent users. The final survey was entered into the Research Electronic Data Capture (REDCap) System, a web application for building and managing online surveys and databases 13 . Approval was then obtained from the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (Reference Number UW 15-514). The survey website was launched on 14 March 2016 and was closed on 9 May 2016. Consent was obtained at the time of answering the questionnaire.
Potential respondents were invited in one of two ways. The first was an invitation via email when email addresses were available from one of the sources listed below. The system was programmed to send a reminder invitation two weeks after sending the first email. The program did not collect any internet protocol addresses or other identifiable data but treated each email address as an individual respondent. The second mode of invitation was a public link directing the reader to the survey site. This link was published in newsletters of anaesthesia societies. Several anaesthesia colleges and societies were approached via email to facilitate this survey and these are shown in Table 1 . There was the possibility that a recipient could receive more than one invitation but they were instructed in the preamble to respond to the survey only once.
Once the survey website was closed, the data was exported to an Excel database for processing. As the absolute number of recipients was unknown due to invitation via the internet, maximum and minimum return rates were estimated from the minimum (3,275 individual invitations sent) and maximum number of recipients of the invitation (4,175, which included the 3,275 individual invitations plus the 900 members of the New Zealand Society of Anaesthetists and the College of Anaesthetists of Ireland invited via the invitation in their email newsletters).
Under the REDCap system, all compulsory questions of the survey must be answered before it is considered complete and therefore, all analysed surveys do not contain missing data. Any incomplete surveys were flagged and were then manually scanned to ascertain the reason for being incomplete and were not included in the final analysis. The REDCap program provided basic descriptive statistics.
Statistical analysis
Results were stratified according to the frequency of TIVA use. Respondents using TIVA for less than 5% of anaesthesia procedures were designated as infrequent users, those with 5% to 50% TIVA usage were considered intermediate users and those whose TIVA usage exceeding 50% were combined into a frequent user group. Data specifying reasons for not using TIVA are presented as a percentage of respondents who considered the respective reasons 'extremely' or 'very' over the total number of respondents in that group. Descriptive statistics of the answers to our survey are presented. To identify possibly interesting correlations among different questions, we exploratively screened all questions pairwise using a chi-square test with a significance level of lower than 0.05. All calculations were performed with Statistical Package for the Social Sciences (SPSS, version 24 for Windows) and graphical depictions were generated using R version 3.3.0 (www.r-project.org).
Results
We individually invited 3,275 participants by email and opened the survey to another 900 via email newsletters. The total number of responses was 842. Minimum and maximum return rates were estimated to be 20.1% and 25.7%, respectively. Of the 842 responses, 763 were considered complete, which was subsequently confirmed by manual scrutiny of the data, and were included in the final data analysis. The demographic data are presented in Table 2 . Results were stratified according to infrequent users (n=316, 41.4%), intermediate users (n=323, 42.3%) and frequent users (n=124, 16.3%). Data specifying reasons for not using TIVA are summarised in Table 3 . It is worth noting that TCI is not yet available in the United States but less than 10% of . When considering the entire cohort, the majority opted for target-controlled over manual infusion when using TIVA (646 out of 763 or 85% answered always, very likely or likely). The percentage opting for TCI was lower in the infrequent users group (250 out of 316 or 79%) compared to the frequent users (112 out of 124 or 90%, Figure 1A ). While the majority in all age groups preferred TCI, younger respondents were more likely to always use TCI for TIVA than older respondents ( Figure 1B ). The other TCI-related barriers to TIVA use, 'Pharmacokinetic models not accurate' and 'Complicated pharmacokinetic models', were rated important by 17% and 15% of infrequent users, and 6% and 2% of frequent users, respectively (Table 3) . 'Institutional preference' was identified as an important barrier to using TIVA by 34% of infrequent users, 17% of intermediate, and 4% of frequent users. Stratifying results by respondent age showed that institutional preference is most relevant for younger anaesthetists and decreases in importance for older and more experienced anaesthetists (P <0.0001, Figure 2A) .
The most important barriers identified by infrequent users were 'additional effort', 'lack of real-time monitoring of propofol concentration' (Figure 2B ), 'institutional preference', 'risk of missing drug delivery failure' and 'intravenous (IV) access-related issues'. For those with increasing frequency of TIVA use, however, 'additional effort' was perceived as less important, with only 35% (113 out of 323) of intermediate users and 11% (14 out of 124) of frequent users, compared with 40% (127 out of 316) for infrequent users (P <0.0001, Figure 3A ) considering this a barrier. Similarly, a 'lack of real-time monitoring of propofol concentration' (127 out of 316 or 40%), became less important for intermediate (76 out of 323 or 24%) or frequent (12 out of 124 or 10%) TIVA users (P <0.0001, Figure 2B ). Non-technical factors such as 'increased turnover time' (Figure 3B , P <0.0001) and 'additional expense' (P <0.0001) also decreased in importance as frequency of TIVA use increased (P <0.0001, Table 3 ). Likewise, the perceived importance of other monitoring-related factors such as 'difficult to predict wake- Values are number of respondents considering the respective reasons 'extremely important' or 'very important' over the total number of recipients in that group (%). TCI, target-controlled infusion; TIVA, total intravenous anaesthesia. up' (P <0.0001) and 'unavailability of depth of anaesthesia monitoring' (P=0.0022) was higher in infrequent than in frequent TIVA users (Table 3 ). In comparison, for frequent TIVA users, the most important factor was 'difficult IV access', followed by 'concealed IV access' (IV access not readily visible or accessible), 'unavailability of TCI pumps', 'unavailability of depth of anaesthesia monitor' and the consideration that 'volatile is better' for that occasion (Table 3) .
Discussion
This survey naturally embodies all the inherent shortcomings of this research approach such as difficult sizing of online populations and non-response tracking. Since some individuals are more likely to participate in an online survey than others, self-selection bias cannot be excluded 14, 15 . In addition to these generic limitations, we acknowledge that the survey was designed following responses to a focus group from only one institution and may bias the nature The area of the tiles is proportional to the number of respondents in each category. TCI, target-controlled infusion; TIVA, total intravenous anaesthesia. and/or scope of the questions. Furthermore, there was no opportunity for responders to enter free text, a process that may have identified additional barriers not included in the survey. It is within this framework of limitations we interpreted our data. The response rate to our survey was reasonable for this type of survey. Nora et al 16 , who individually contacted 252 anaesthetists for a similar survey, received 98 responses (response rate 39%). We would expect response rates to individual invitations to be much higher than to nonindividual announcements in newsletters etc. Thus, although our response rate is lower compared to Nora et al, it appears reasonable when taking into account our broad approach to contact possible participants. Furthermore, the larger absolute number of analysable responses provides some insight into the reasons behind the choice to use or not to use TIVA.
One of the most striking findings is that 52% of infrequent TIVA users perceived the additional effort of performing TIVA as the most significant factor for deciding not to use it. This outranks their concerns regarding the ability to monitor the delivery of the anaesthetic agent. Despite the well-known evidence regarding benefits of TIVA, up to a quarter of the infrequent users seem to consider no outcome benefits to be important when taking into account the extra work required to set up and monitor TIVA. Only 30% of this group, however, considered inhalation anaesthesia to be better than TIVA. Interestingly, institutional preference and increased turnover time between cases ( Figure 3B ), arguably non-technical considerations, also ranked highly on the list of barriers to TIVA. Institutional preference is important for many young respondents but much less so for older ones (Figure 2A ), likely because senior anaesthetists often define the institutional preference.
Given that most anaesthetists receive their basic training with inhalational anaesthesia and continuous gas monitoring, it is not surprising that many are reluctant to abandon this habit. Yet for only 10% of those regularly using TIVA was this still a concern, indicating a substantial gap between perceived and real issues with the lack of real-time anaesthetic delivery monitoring ( Figure 2B ). Being trained first with the inhalation technique may inadvertently dissuade one from trying TIVA owing to the time it requires to acquire expertise in the one technique. Though difficult to define objectively how and when one achieves expertise, especially in anaesthesia, scholars in research into performance would agree that a period of deliberate practice is necessary and the figure of 10,000 hours has been classically quoted 17 . Given most training programs would not come close to this amount of time, practitioners may err towards mastering one technique before embarking on another.
Similarly, frequent users have quite a different view of the other obstacles for using TIVA, with 25% naming difficult IV access as the most important reason, followed by unavailability of TCI pumps (22%) and concealed IV access (22%). The frequent users do not appear to be deterred by the apparent additional effort required to deliver TIVA, the lack of real-time monitoring of propofol concentration or the risk of missing drug delivery failure. They were also less concerned with institutional preferences but were inhibited more by practical issues such as difficult IV access.
What frequent and infrequent users tend to agree on is the understanding of the pharmacokinetic models. This may reflect a general trust in the reliability of these models after as barriers to using TIVA. The area of the tiles is proportional to the number of respondents in each category. TIVA, total intravenous anaesthesia.
more than 20 years of use in clinical practice. Regardless of the frequency of TIVA use, most respondents prefer TCI over manual infusion ( Figure 1A ). Stratifying the respondents by age reveals that, although the majority of all age groups prefer TCI, the preference is stronger in younger respondents ( Figure 1B) . This is somewhat surprising as there is much debate among TCI experts about the best models for clinical practice, the pharmacokinetic TCI models for propofol are evolving constantly, and there are still limitations in extreme obesity, very young and very old patients 18 . Why are there such divergent views over similar issues, e.g. efforts and perception of reliability? An obvious explanation is that with growing familiarity, practitioners are getting better at titrating TIVA and more confident in their choices of dosing. Thus, factors such as inter-patient variability in dose requirements, difficulties during induction and in predicting wake-up time are less of a concern for them. With frequent use, TIVA-optimised resource allocation and economies of scale, practical issues such as additional effort, increased turnover time and additional expense may also become less relevant or may even disappear. Consistently, unavoidable limitations such as unavailability of TCI pumps or problems with IV access are the most relevant for frequent TIVA users.
Another possibility for divergent views is the influence of non-technical or human factors in clinical decision-making regarding the use of TIVA. Anaesthetists are very cognisant of the role human factors play in crisis resource management and error prevention as evidenced by the early adoption of crew resource management training by our specialty 19 . What may be overlooked is the impact of these factors in nonemergency clinical decisions. In their landmark dissertation, Nobel prize winners Tversky et al discussed the concepts of heuristics and bias that laid the foundation for the subsequent recognition and study of a number of cognitive biases and errors that affect decision-making 20 . Fomberstein et al have reviewed a list of these which are applicable to the clinical context 21 . In this survey, cognitive biases could account for the differences in the responses on accidental awareness under anaesthesia and on outcome benefits. Presumably users from both groups would be familiar with the incidence of accidental awareness under anaesthesia, cited as 1 in 19,000 to 1 in 1,000 anaesthetic cases, with the occurrence being twice as likely during TIVA procedures than during inhalation-based techniques [22] [23] [24] . Yet there is a ten-fold difference between the user groups in how this factor affects their decision. Could it be that frequent users focus more on the small absolute risk while infrequent users are mainly focusing on the large relative risk? Without confirmatory qualitative data however, it would be difficult to uncover the root cause for the difference.
Although a previous survey by Nora et al in 2006 was much smaller and was done solely in Brazil, it showed some similarities to our results; the respondents to this survey thought that TIVA requires more knowledge about the anaesthetic used than volatile anaesthesia. Furthermore, cost appeared to be a relevant barrier to the use of TIVA. Both surveys showed that training and experience is an important factor affecting the frequency of TIVA use. However, while for 53% of respondents to the survey of Nora et al considered cost a relevant drawback for using TIVA, additional costs were only mentioned by 28% of infrequent users in our survey. Insufficient TIVA training and experience appears to still be relevant 11 years after the survey of Nora et al, while cost might have become less relevant. However, because of the different healthcare systems represented in both surveys, the validity of a direct comparison might be limited.
Exploring the reasons underlying the relative importance of factors that contribute to the decision to use or not to use TIVA may help to increase its use, but is the low usage of TIVA really a cause for concern? It is of interest that the authors of the 5th National Audit Project (NAP5) report wrote that "all anaesthetists are likely to need to use TIVA, particularly in sites/circumstances when a volatile cannot be administered, and need to be skilled in its administration" 25 . In contrast, our results suggest that this is currently not the case. Currently, given the low use of this technique in routine surgery, it is difficult to see how young anaesthetists can be adequately trained in the use of TIVA. It is highly likely, considering our own personal experience in teaching, that many hospitals will not even have one specialist who is regularly using this technique. Despite learning the theory of TIVA and propofol pharmacology, many trainees will never be properly trained how to use it. Unfamiliarity with a technique is also more conducive to errors, especially if TIVA is only performed as a kind of last resort in difficult patients and circumstances. Thus, it is conceivable that the technique is caught in a vicious circle of low usage, leading to more unfavourable experiences that in turn result in protracted low usage.
Conclusion
We have demonstrated that frequent and infrequent users of TIVA respond to similar TIVA-related factors quite differently, and non-technical factors may play an important role in the infrequent user's decision not to use TIVA for a particular case. Given the wide availability of TCI pumps, generic propofol and electroencephalogram-based depth of anaesthesia monitoring, we suggest that additional TIVA training with an emphasis on practical application may help to overcome the perceived and real barriers for infrequent users.
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